Log in

Achieve Life Sciences News Headlines (NASDAQ:ACHV)

$1.48
-0.06 (-3.90 %)
(As of 10/20/2019 01:14 PM ET)
Today's Range
$1.48
Now: $1.48
$1.58
50-Day Range
$1.47
MA: $1.94
$2.40
52-Week Range
$1.04
Now: $1.48
$4.63
Volume77,796 shs
Average Volume112,627 shs
Market Capitalization$11.99 million
P/E RatioN/A
Dividend YieldN/A
Beta1.92

Headlines

Achieve Life Sciences (NASDAQ ACHV) News Headlines

Source:
DateHeadline
Achieve Life Sciences Inc (NASDAQ:ACHV) Short Interest UpdateAchieve Life Sciences Inc (NASDAQ:ACHV) Short Interest Update
www.americanbankingnews.com - October 11 at 10:20 PM
 Analysts Expect Achieve Life Sciences Inc (NASDAQ:ACHV) to Post -$0.22 Earnings Per Share Analysts Expect Achieve Life Sciences Inc (NASDAQ:ACHV) to Post -$0.22 Earnings Per Share
www.americanbankingnews.com - October 10 at 9:19 AM
Achieve Life Sciences (ACHV) Buy Rating Reaffirmed at Maxim GroupAchieve Life Sciences' (ACHV) Buy Rating Reaffirmed at Maxim Group
www.americanbankingnews.com - October 1 at 4:04 PM
Achieve Life Sciences Announces Completion of Maximum Tolerated Dose StudyAchieve Life Sciences Announces Completion of Maximum Tolerated Dose Study
finance.yahoo.com - September 30 at 8:36 AM
Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual ConferenceAchieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
finance.yahoo.com - September 13 at 8:47 AM
What Kind Of Share Price Volatility Should You Expect For Achieve Life Sciences, Inc. (NASDAQ:ACHV)?What Kind Of Share Price Volatility Should You Expect For Achieve Life Sciences, Inc. (NASDAQ:ACHV)?
finance.yahoo.com - September 9 at 12:01 PM
Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 TrialAchieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
finance.yahoo.com - September 7 at 3:46 PM
Achieve Life Sciences, Inc. Institutional OwnershipAchieve Life Sciences, Inc. Institutional Ownership
www.nasdaq.com - September 2 at 6:51 PM
ACHV: SRNT Presentation Next on AgendaACHV: SRNT Presentation Next on Agenda
finance.yahoo.com - August 26 at 7:45 PM
Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q2 2019 Results - Earnings Call TranscriptAchieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 9:07 AM
/C O R R E C T I O N -- Achieve Life Sciences, Inc.//C O R R E C T I O N -- Achieve Life Sciences, Inc./
finance.yahoo.com - August 9 at 9:07 AM
Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
finance.yahoo.com - July 30 at 8:47 AM
Did You Manage To Avoid Achieve Life Sciencess (NASDAQ:ACHV) Painful 55% Share Price Drop?Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop?
finance.yahoo.com - July 10 at 6:52 PM
Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop?Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop?
finance.yahoo.com - July 10 at 6:52 PM
Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At ConferenceAchieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At Conference
finance.yahoo.com - June 21 at 7:36 PM
Achieve Life Sciences up 15% premarket after cytisinicline data accepted for presentationAchieve Life Sciences up 15% premarket after cytisinicline data accepted for presentation
seekingalpha.com - June 21 at 10:33 AM
Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual ConferenceAchieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
finance.yahoo.com - June 21 at 10:33 AM
ACHV: ORCA-1 Topline Results and ComparisonACHV: ORCA-1 Topline Results and Comparison
finance.yahoo.com - June 12 at 5:45 PM
Achieve Life Sciences Reports 74-80% Median Reduction In Smoking In StudyAchieve Life Sciences Reports 74-80% Median Reduction In Smoking In Study
feeds.benzinga.com - June 11 at 10:31 AM
Achieve Life Sciences up 16% premarket on positive cytisinicline dataAchieve Life Sciences up 16% premarket on positive cytisinicline data
seekingalpha.com - June 11 at 8:42 AM
Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection TrialAchieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
finance.yahoo.com - June 11 at 8:42 AM
ACHV: 1Q:19 Financial & Operational UpdateACHV: 1Q:19 Financial & Operational Update
finance.yahoo.com - May 30 at 6:43 PM
Achieve Life Sciences nabs new patent in U.S.; shares up 7% premarketAchieve Life Sciences nabs new patent in U.S.; shares up 7% premarket
seekingalpha.com - May 30 at 8:28 AM
Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q1 2019 Results - Earnings Call TranscriptAchieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 9:15 AM
Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019
finance.yahoo.com - May 15 at 9:00 PM
Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development UpdateAchieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update
finance.yahoo.com - May 15 at 9:00 PM
ACHV: Final Enrollee, Final VisitACHV: Final Enrollee, Final Visit
finance.yahoo.com - April 26 at 6:57 PM
Achieve Life Sciences up 9% premarket as cytisinicline study nears finish lineAchieve Life Sciences up 9% premarket as cytisinicline study nears finish line
seekingalpha.com - April 24 at 8:20 AM
Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019
finance.yahoo.com - April 3 at 8:18 AM
Achieve Life Sciences +13% on DSMC review of phase 2b ORCA-1 trialAchieve Life Sciences +13% on DSMC review of phase 2b ORCA-1 trial
seekingalpha.com - April 2 at 8:40 AM
ACHV: Fiscal Year 2018 Operational and Financial ResultsACHV: Fiscal Year 2018 Operational and Financial Results
finance.yahoo.com - March 25 at 7:35 PM
Achieve Life Sciences, Inc. (ACHV) Pre-Market TradingAchieve Life Sciences, Inc. (ACHV) Pre-Market Trading
www.nasdaq.com - March 19 at 7:46 PM
What Do the Clinical Updates at Achieve Life Sciences Mean for CytisiniclineWhat Do the Clinical Updates at Achieve Life Sciences Mean for Cytisinicline
finance.yahoo.com - March 18 at 8:02 PM
Achieve Life Sciences to Present at Oppenheimers 29th Annual Healthcare Conference on March 20, 2019Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019
finance.yahoo.com - March 18 at 8:14 AM
Achieve Life Sciences Inc.Achieve Life Sciences Inc.
www.barrons.com - March 16 at 8:26 AM
Achieve Life Sciences up 83% on advancement of cytisinicline - Seeking AlphaAchieve Life Sciences up 83% on advancement of cytisinicline - Seeking Alpha
seekingalpha.com - March 15 at 7:30 PM
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q4 2018 Results - Earnings Call TranscriptAchieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 15 at 8:30 AM
Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development UpdateAchieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
finance.yahoo.com - March 14 at 7:20 PM
ACHV: A Reason to Quit is a Reason to BuyACHV: A Reason to Quit is a Reason to Buy
finance.yahoo.com - March 12 at 10:49 PM
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019
finance.yahoo.com - March 5 at 8:44 AM
Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful?Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - February 25 at 8:36 AM
Achieve Life Sciences stock rockets on heavy volume after update results of smoking-cessation drug trialAchieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial
www.marketwatch.com - February 22 at 7:06 PM
Achieve Life Sciences up 57% premarket on positive cytisinicline dataAchieve Life Sciences up 57% premarket on positive cytisinicline data
seekingalpha.com - February 22 at 7:06 PM
Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual MeetingAchieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting
finance.yahoo.com - February 22 at 8:22 AM
Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking CessationAchieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation
finance.yahoo.com - February 20 at 8:24 AM
Biocept leads healthcare gainers; Achieve Life Sciences and Revance Therapeutics among losers - Seeking AlphaBiocept leads healthcare gainers; Achieve Life Sciences and Revance Therapeutics among losers - Seeking Alpha
seekingalpha.com - January 16 at 5:55 PM
5 Top Rising P/E Stocks to Enjoy Solid Gains5 Top Rising P/E Stocks to Enjoy Solid Gains
finance.yahoo.com - December 28 at 8:27 AM
Achieve Announces Update on Cytisinicline Clinical Development ProgramAchieve Announces Update on Cytisinicline Clinical Development Program
finance.yahoo.com - December 18 at 8:20 AM
5 Top-Ranked Rising P/E Stocks to Lure Investors5 Top-Ranked Rising P/E Stocks to Lure Investors
finance.yahoo.com - November 28 at 8:25 AM
Prometic Life Sciences Inc. (PFSCF) CEO Brad Hansen on Q3 2018 Results - Earnings Call TranscriptPrometic Life Sciences Inc. (PFSCF) CEO Brad Hansen on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 15 at 5:27 PM
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Featured Article: Is the QQQ ETF safe?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel